Abnormal expression of E-cadherin occurs even in early gastric carcinomas [79], and abnormal E-cadherin immunoreactivity occurs markedly more frequently in tumour cells of diffuse type compared with those of intestinal type [80]. Here, CDH1 is linked to gastric carcinoma.